EUVIMEDEUVIMED entdecken
Open Access

New Cancer Diagnoses Before and During the COVID-19 Pandemic

Kathleen M Decker, Allison Feely, Oliver Bucher, Piotr Czaykowski, Pamela Hebbard, Julian O Kim, Marshall Pitz, Harminder Singh, Maclean Thiessen, Pascal Lambert

JAMA Network Open · 2023

DOI: 10.1001/jamanetworkopen.2023.32363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2023. Verfasst von Kathleen M Decker und 9 weiteren Autor:innen. Beteiligte Einrichtung: Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: COVID-19, Lung Neoplasms, Melanoma. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Disruptions to health care during the COVID-19 pandemic may have led to missed cancer diagnoses. It is critical to evaluate the association between the COVID-19 pandemic and cancer incidence to address public and patient anxiety, inform recovery efforts, and identify strategies to reduce the system’s vulnerability to future disruptions.

Objective

To examine the association between the COVID-19 pandemic and cancer incidence in Manitoba, Canada. Design, Setting, and Participants A population-based cross-sectional study design was conducted using data from the Manitoba Cancer Registry and an interrupted time-series analysis. All individuals diagnosed with cancer in Manitoba, Canada, from January 1, 2015, until December 31, 2021, were included. Individuals diagnosed with breast, colon, rectal, or lung cancer were grouped by age as follows: younger than 50 years, 50 to 74 years, and 75 years and older. Exposures COVID-19 pandemic. Main Outcomes and Measures Age-standardized cancer incidence rates and the estimated cumulative difference between the number of cases in the absence of COVID-19 and observed (fitted) number of cancer cases.

Results

A total of 48 378 individuals were included. The median (IQR) age at diagnosis was 68 (59-77) years and 23 972 participants (49.6%) were female. In April 2020, there was a 23% decrease in overall cancer incidence. Cancer incidence decreased by 46% for breast, 35% for colon, 47% for rectal, 50% for head and neck, 65% for melanoma, and 33% for endocrine cancer diagnoses and increased by 12% for hematological cancer diagnoses and 8% for diagnoses of cancers with an unknown primary site. Lung cancer incidence remained stable until December 2020 when it decreased by 11%. Brain and central nervous system and urinary cancer diagnoses decreased consistently over time from April 2020 to December 2021 by 26% and 12%, respectively. No association was observed with gynecologic (1% increase), other digestive (1% decrease), or pancreatic (7% increase) cancer incidence. As of December 2021, Manitoba had an estimated deficit of 692 (5.3%) cancers. The largest estimated deficits were for breast (273 cases, 14.1% deficit), colon (133 cases, 12.2% deficit), and lung cancers (132 cases, 7.6% deficit). Conclusions and Relevance In this study, the COVID-19 pandemic was associated with an initial decrease in cancer diagnosis incidence followed by a recovery for most cancer sites. However, the cumulative deficit for some cancers with high fatality needs immediate attention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Lung NeoplasmsMelanomaFemaleHumansMiddle AgedMaleCross-Sectional StudiesPandemics

Autor:innen und Institutionen

  • Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Section of General Surgery, Department of Surgery, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Förderung

  • CIHR

Zitieren

APA

Decker, K. M., Feely, A., Bucher, O., Czaykowski, P., Hebbard, P., Kim, J. O., Pitz, M., Singh, H., Thiessen, M., & Lambert, P. (2023). New Cancer Diagnoses Before and During the COVID-19 Pandemic. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.32363

Vancouver

Decker KM, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, et al. New Cancer Diagnoses Before and During the COVID-19 Pandemic. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.32363

BibTeX
@article{Decker2023,
  author = {Decker, Kathleen M and Feely, Allison and Bucher, Oliver and Czaykowski, Piotr and Hebbard, Pamela and Kim, Julian O and Pitz, Marshall and Singh, Harminder and Thiessen, Maclean and Lambert, Pascal},
  title = {New Cancer Diagnoses Before and During the COVID-19 Pandemic},
  journal = {JAMA Network Open},
  year = {2023},
  doi = {10.1001/jamanetworkopen.2023.32363}
}
Kostenlos starten →